Experimental pyelonephritis in primates.
D000818:Animals; D000917:Antibody Formation; D000942:Antigens, Bacterial / Q000008:administration & dosage*; D001012:Aorta, Abdominal; D002425:Cautery; D004926:Escherichia coli / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000150:complications / Q000209:etiology; D005260:Female; D000882:Haplorhini; D007114:Immunization; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D007668:Kidney / Q000293:injuries / Q000382:microbiology; D008297:Male; D009392:Nephrectomy; D010215:Papio; D011704:Pyelonephritis / Q000209:etiology / Q000276:immunology*; D012077:Renal Artery; D014556:Urine / Q000382:microbiology
D000942:Antigens, Bacterial